Zhongliang Q. Shen

419 Fang Xie Road
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Zinc finger protein ZBTB7A suppresses hepatitis B virus replication by attenuating FXRα-mediated HBV transcription and lowering covalently closed circular DNA levels.

Zinc finger protein ZBTB7A suppresses hepatitis B virus replication by attenuating FXRα-mediated HBV transcription and lowering covalently closed circular DNA levels.

Journal: Antiviral research

Published: February 10, 2026

Host-viral interaction of HBV infection revealed by single-cell transcriptome jointly profiling the viral replication state.

Host-viral interaction of HBV infection revealed by single-cell transcriptome jointly profiling the viral replication state.

Journal: Hepatology (Baltimore, Md.)

Published: August 09, 2025

The host gene CSTF2 regulates HBV replication via HBV PRE-induced nuclear export.

The host gene CSTF2 regulates HBV replication via HBV PRE-induced nuclear export.

Journal: Acta biochimica et biophysica Sinica

Published: December 26, 2024

Identification and characterization of host factor VCPIP1 as a multi-functional positive regulator of hepatitis B virus.

Identification and characterization of host factor VCPIP1 as a multi-functional positive regulator of hepatitis B virus.

Journal: Journal of virology

Published: November 04, 2024

Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein.

Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein.

Journal: PLoS pathogens

Published: August 13, 2024

Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.

Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.

Journal: Journal of virology

Published: January 16, 2024

PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial.

PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial.

Journal: Journal of hepatology

Published: January 15, 2024

Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.

Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.

Journal: The Journal of infectious diseases

Published: July 18, 2023

Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.

Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.

Journal: Journal of medical virology

Published: April 04, 2023

Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.

Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.

Journal: Journal of medical virology

Published: March 17, 2023

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation.

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation.

Journal: Frontiers in cellular and infection microbiology

Published: December 09, 2022

BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion.

BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion.

Journal: Nature communications

Published: November 27, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026